Skip to content

Randomized Assessment of Devices Used to Prevent Post-operative Hemorrhagic Risk in Endonasal Surgery

Randomized Medico-economic Assessment of Preventive Devices Used for Post-operative Hemorrhagic Risk in Endonasal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03243344
Acronym
PRHEPOCE
Enrollment
571
Registered
2017-08-09
Start date
2010-03-31
Completion date
2013-05-31
Last updated
2017-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otorhinolaryngologic Diseases

Brief summary

This study evaluates the efficiency and the cost of three medical devices and the abstention of the use of specific product for the post-operative haemostasis in endonasal surgery .

Detailed description

Surgiflo® is a matrix of haemostatic frost of porcine protein origin is the coverage of the post-operative bleeding of which one of the indications is in endonasal surgery. Floseal® is a haemostatic frost(gel) containing of the thrombin. Algosteril® is a lint tent of arginate of calcium.

Interventions

DEVICESurgiflo

using device during the endonasal surgery.

DEVICEFloseal

using device during the endonasal surgery.

using device during the endonasal surgery.

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* endonasal surgery schedule * Surgical indications: hypertrophic rhinitis, repeated or chronic infections, extraction of foreign body, polyposes naso-sinusal, benign tumors limited to the nasal pit and in sine,

Exclusion criteria

* Pregnant Woman * Disorder of the haemostasis known or disrupted preoperative biological balance assessment * Use of treatment disrupting the blood coagulation (anti platelet, anti vitamin K, AINS) * Unchecked HTA by the treatment and/or preoperative \> mmHg 160/90 * Surgical Act including a septoplasty * malignant tumoral surgical Indication, or mild overtaking the naso-sinusial system * Dacryocystorhinostomy

Design outcomes

Primary

MeasureTime frameDescription
Per-operative hemostasisHours 0Time needs to observe hemostasis after the device set up
Hemostasis in the 6 first hoursHours 6Number of compresses used from Hours 0 to Hours 6.
Hemostasis at the 24th hourHours 24* Algosteril arm (after having removed the wick): spontaneous observation of hemostasis in less that 3 min (yes/no) and needs to have a new intervention to stop bleedings (type) * Surgiflo, Floseal, Abstention arms: time to observe hemostasis if bleedings occurred.
Spontaneous hemorrhagic eventsfrom Hours 0 to Day 45number of spontaneous hemorrhagic events.

Secondary

MeasureTime frameDescription
Preoperative assessmentBefore the endonasal surgeryPreoperative scanner assessment with Lund ans Mackay score
Device evaluation by the surgeonHours 0time needs to set up the device

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026